P63042 (STMN4_MOUSE) Mus musculus (Mouse)

Stathmin-4 UniProtKBInterProSTRINGInteractive Modelling

189 aa; Sequence (Fasta) ; 5 identical sequences: Camelus ferus: A0A8B6YQ91; Peromyscus maniculatus bairdii: A0A6I9LRA0; Rattus norvegicus: P63043, A6K6M9; Mus caroli: A0A6P5QTP6

Available Structures

292 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Tubulin: RB3 stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
48-189
97.79GTP;MG; 11×SO4;GDP;
DROSOPHILA GMPCPP-TUBULIN Heteromer
P06603; P63043; Q24560;
48-189
97.74GTP;MG; 11×SO4;GOL;G2P;
DROSOPHILA GDP-TUBULIN Heteromer
P06603; P63043; Q24560;
48-189
97.69GTP;MG; 11×SO4;GOL;GDP;
GDP-Tubulin: rb3 stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
48-189
97.79GTP;MG; 12×SO4;GDP;
GTP-Tubulin: RB3 Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
48-189
97.79GTP;MG; 11×SO4;
1,1-Diheterocyclic Ethylenes Derived from Quinaldine and Carbazole as New Tubulin Polymerization In… Heteromer
D0VWY9; D0VWZ0; P63043;
48-189
97.7911×SO4;GTP;MG;GDP;FWH;
GMPCPP-Tubulin: RB3 Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
48-189
97.78GTP;MG;SO4;G2P;
DROSOPHILA GDP-TUBULIN Y222F MUTANT Heteromer
P06603; P63043; Q24560;
49-189
98.45GTP;MG; 13×SO4;GOL;GDP;
Tubulin-inhibitor complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-189
98.46SO4;GTP;MG;GDP;N3Z;
Tubulin-cyclostreptin complex Heteromer
P63043; P81947; Q6B856;
50-189
100.0GTP;MG;CA;EDO;GDP;MES;JHH;GOL;ACP;
DROSOPHILA GTP-TUBULIN Y222F MUTANT Heteromer
P06603; P63043; Q24560;
48-187
97.64GTP;MG;SO4;GDP;
TUBULIN-MTC complex Heteromer
P63043; P81947; Q6B856;
50-188
100.0GTP;MG;CA;GOL;8WB;GDP;MES;ACP;
Crystal structure of tubulin-stathmin-TTL complex Heteromer
P63043; P81947; Q6B856;
50-188
100.0GTP;MG;CA;CL;GDP;MES;ACP;
EPB in complex with tubulin Heteromer
P02554; Q2XVP4;
50-188
100.0GTP;MG;CA;CL;GDP;MES;EPB;ACP;
Crystal structure of tubulin-inhibitor complex Heteromer
P02554; Q2XVP4;
50-188
100.0GTP;MG;CA;CL;GDP;MES;ERR;ACP;
Tubulin Polymerization Inhibitors Heteromer
P02554; Q2XVP4;
50-188
100.0GTP;MG;CA;CL;GDP;MES;ERX;ACP;
IC1 in complex with tubulin Heteromer
P02554; Q2XVP4;
50-188
100.0GTP;MG;CA;GDP;MES;IC1;ACP;
Tubulin-MMAE complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;4Q5;ACP;
Crystal structure of tubulin-RB3-TTL-Zampanolide complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GOL;GDP;TYR;MES;ZPN;ACP;
Tubulin-maytansinoid-12 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;IMD;GDP;MES;PWC;ACP;
Tubulin-Z32400357-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;NZJ;ACP;
Tubulin-Discodermolide complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;7AK;ACP;
Tubulin-Z57472297-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;AYV;ACP;
Tubulin-CW1-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;KLC;ACP;
Tubulin-B2 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;GOL;GDP;L95;MES;ACP;
Tubulin-nocodazole complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;GDP;MES;NW6;ACP;
Tubulin-BKM120 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;SD5;ACP;
Tubulin-Z396380540-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;HR5;ACP;
Tubulin-TUB015 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;DLK;ACP;
Tubulin-Z1896597864-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;X1M;ACP;
Tubulin-todalam-18-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;4I2;ACP;
Tubulin-Z28290384-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WN1;ACP;
tubulin-Disorazole Z complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;DKN;ACP;
Tubulin-Z2856434929-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;GDP;MES;LVV;ACP;
Tubulin-pironetin complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;X3H;ACP;
Tubulin-Laulimalide complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;LLM;GOL;ACP;
Tubulin-PTC596 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GOL;SOZ;EDO;IMD;ACP;
Tubulin-7j complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;GOL;GDP;MES;A9Q;CA;IMD;ACP;
Tubulin-inhibitor complex Heteromer
P63043;
48-185
97.66SO4;GTP;MG;GDP;N9B;
Tubulin-MTD265 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;918;GDP;MES;ACP;
Tubulin-TUB075 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;DLW;GDP;MES;PG4;ACP;
Tubulin-Z2142244288-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;WV4;GDP;MES;ACP;
Tubulin-18-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;IAZ;ACP;
tubulin-cryptophycin complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;IMD;MES;GOL;Y74;ACP;
Tubulin-7-Aminonoscapine complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;OBQ;MES;GOL;ACP;
Tubulin-KS-1-199-32 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;7AO;MES;ACP;
Tubulin-Peloruside A complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;POU;ACP;
Tubulin-Peloruside A-Epothilone A complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;POU;EP;MES;
Tubulin-noscapine-analogue-14e complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GOL;RYK;IMD;ACP;
TUBULIN-MTC-zampanolide complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;8WB;8WE;GOL;MES;ZPN;ACP;
Tubulin-Z87615031-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;UQM;ACP;
Tubulin-MTD147 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;FB7;GDP;MES;ACP;
Tubulin - maytansinoid - 6 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GOL;PX0;ACP;
Tubulin MTD265-R1 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;UGI;GDP;MES;ACP;
Tubulin-Z1354416068-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;X1J;ACP;
Tubulin-Z2856434783-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;O3G;ACP;
Tubulin-Z1148747945-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WKY;ACP;
Tubulin-Z26781952-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;W0A;ACP;
Tubulin-Z328695024-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;K1G;ACP;
Tubulin-Z275165822-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;WNY;GDP;MES;ACP;
Tubulin-Z33452106-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GVV;ACP;
Tubulin-Z2856434857-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;NSJ;ACP;
Tubulin-maytansinoid-3-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;IMD;5IS;ACP;
Tubulin-Z27695365-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;X1G;ACP;
Tubulin-Z106307058-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;WZP;ACP;
Crystal structure of tubulin-stathmin-TTL-Epothilone A complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GOL;GDP;MES;EP;ACP;
Tubulin-Z906021418-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;K2G;ACP;
Tubulin-Z57040482-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;9KS;ACP;
Tubulin-Z1891773393-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WV1;ACP;
Tubulin-Z2856434826-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;NUY;ACP;
Tubulin-Z48847594-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;O0J;ACP;
Tubulin-Z27682767-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WGY;ACP;
Tubulin-todalam-9-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;4CJ;ACP;
Tubulin-Z45705015-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;S9S;ACP;
Crystal structure of T2R-TTL-Barbigerone complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;MES;J6L;GDP;ACP;
Tubulin-Z240297434-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;K0M;GDP;MES;ACP;
Auristatin bound to tubulin Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;ACP;
Tubulin-Z117233350-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;NW7;ACP;
Tubulin-Z1449748885-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WZY;ACP;
Crystal structure of T2R-TTL-15 complex Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;GX5;
Tubulin-Z53860899-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;STV;ACP;
Tubulin-Z166605480-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;VWA;ACP;
Crystal structure of tubulin with 17j Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GDP;MES;7PB;
Tubulin-Z30620520-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GX4;ACP;
Tubulin-TUB092 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;6NL;GDP;MES;ACP;
Tubulin-Combretastatin A4 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;7BA;MES;ACP;
Tubulin-Z44592329-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;K0G;ACP;
PRA in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;H1C;GDP;MES;ACP;
Tubulin-Z2856434816-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;WLS;ACP;
IXA in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;GZX;ACP;
Tubulin-Z1251207602-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;RWS;ACP;
Tubulin-Laulimalide-Epothilone A complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;EP;LLM;MES;ACP;
Tubulin-STX3451 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;GXN;MES;ACP;
tubulin - rigosertib complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GOL;GDP;6FS;MES;ACP;
Tubulin-FcMaytansine complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;DMS;GDP;MES;PEG;DKE;ACP;
Tubulin-Spongistatin complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;CA;MG;GDP;MES;GOL;DMS;SG9;ACP;
Tubulin-Z2472938267-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;S6V;ACP;
Crystal structure of T2R-TTL-Cevipabulin-eribulin complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;G2X;6K9;ACP;
The structure of SB-1-202-tubulin complex Heteromer
P63043; Q2XVP4; Q6B856;
49-186
100.0GTP;MG;CA;CL;GOL;GDP;MES;J7S;ACP;
Tubulin-Z2856434883-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;WZS;ACP;
RYX in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;H1O;
Crystal structure of T2R-TTL-KXO1 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;DN0;ACP;
Tubulin-Z295848548-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;X0G;ACP;
Drug cocktail (Colchicine, Epothilone A, Peloruside, Ansamitocin P3, Vinblastine) bound to tubulin … Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;LOC;EP;POU;VLB;BKF;ACP;
Tubulin-Z1124201124-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;GOJ;ACP;
Tubulin-BAL27862 complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GOL;IMD;GDP;2RR;MES;ADP;
Crystal structure of tubulin with 3 Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;PEG;7PL;ACP;
Tubulin-todalam-8-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;4B6;ACP;
CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-Vinblastine COMPLEX Heteromer
P02554; P63043; P81947;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;VLB;ACP;
Tubulin-Z2074076908-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WLG;ACP;
Tubulin-MMAF complex Heteromer
P38584; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;ACP;
Crystal structure of tubulin in complex with L-DM1-SMe Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;BKX;ACP;
CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-HTI286 COMPLEX Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;4SL;ACP;
Tubulin-Z285782452-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;UVA;ACP;
Tubulin-Z2856434917-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;JHD;ACP;
Tubulin-Z198194394-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;O1M;ACP;
Crystal structure of Tubulin-Stathmin-TTL-MMAE Complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GOL;GDP;MES;4Q5;ACP;
Tubulin-Z2856434944-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;AWD;ACP;
T2R-TTL-1-L01 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;IMD;GDP;MES;A1H00;GOL;ACP;
Crystal structure of the apo human TTL in complex with tubulin-stathmin Heteromer
P63043; P81947; Q6B856; Q8NG68;
51-188
99.19MG;GTP;GDP;ACP;
Tubulin-Z422344882-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WVD;ACP;
Crystal structure of tubulin-stathmin-TTL-apo complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GDP;MES;
Tubulin-Z1324080698-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;UR1;GDP;MES;ACP;
Tubulin-Z2241115980-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;NV7;ACP;
Crystal structure of T2R-TTL-A31 complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;FUO;MES;GDP;
Crystal structure of T2R-TTL-Cevipabulin complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GDP;MES;G2X;ACP;
Tubulin-Z1515654336-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;UQJ;ACP;
Crystal structure of T2R-TTL-Y61 complex Heteromer
A0A8V0Z8P0; P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;MES;USI;GDP;CL;ACP;
Crystal structure of tubulin in complex with Maytansinol Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;MES;GDP;BKL;ACP;
Tubulin-Z1129283193-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;SZY;ACP;
Crystal structure of T2R-TTL-BML-284 complex Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GDP;MES;FW9;CL;ACP;
Tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100GTP;MG;CA;GDP;ACP;
Crystal structure of T2R-TTL-27a complex Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;GWC;
Tubulin-Z45527714-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;X0S;ACP;
Tubulin-Z32386228-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;HR8;ACP;
Crystal structure of tubulin in complex with L-DM4-SMe Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;BKU;ACP;
BNC105 in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;DO6;GDP;MES;GOL;
Tubulin-Z28870646-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;TVP;ACP;
Tubulin-maytansinoid-5c-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;5L5;ACP;
Tubulin-Z100642432-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WJ7;ACP;
Tubulin-Z1349163663-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WZM;ACP;
Tubulin-Y62 Heteromer
A0A8V0Z8P0; P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;MES;UPO;GDP;CL;ACP;
Tubulin-Z53825177-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;VVG;ACP;
Epothilone A and Colchicine bound to tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-187
100GTP;MG;CA;EP;LOC;GDP;ACP;
Tubulin-Z1416571195-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WZ7;ACP;
SSE in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;GDP;MES;H1F;ACP;
Crystal structure of T2R-TTL-3a complex Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;GY2;
Tubulin-Z50145861-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;W1P;ACP;
Structure of Tubulin Tyrosine Ligase in Complex with Tb116 Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GDP;MES;O9B;O9K;O9N;PGE;VAL;P6S;PEG;ACP;
Crystal structure of tubulin with 17a Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;CL;GDP;MES;7PU;
Tubulin-Z165170770-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;W0Y;ACP;
444 in complex with tubulin Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;H0U;GDP;MES;ACP;
Tubulin-Z57299526-complex Heteromer
P63043; P81947; Q6B856;
50-187
100.0GTP;MG;CA;GDP;MES;WZD;ACP;
Structure of Tubulin Tyrosine Ligase in Complex with Tb111 Heteromer
P02554; P63043; Q2XVP4;
50-187
100.0GTP;MG;CA;GDP;MES;O9B;O9H;OH5;PGE;VAL;ACP;
Crystal structure of T2R-TTL-27a complex Heteromer
P02554; Q2XVP4;
50-187
100.0GTP;MG;CA;CL;GDP;MES;GXI;
TUBULIN-COLCHICINE: STATHMIN-LIKE DOMAIN COMPLEX Heteromer
P63043; Q2HJ86; Q6B856;
48-185
99.19MG;GTP;GDP;CN2;
Tubulin-colchicine-vinblastine: stathmin-like domain complex Heteromer
P63043; Q2HJ86; Q6B856;
48-185
99.19MG;GTP;GDP;CN2;VLB;
Tubulin-Todalam-Vinblastine-complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;VLB;4I2;ACP;
Tubulin-PM060184 complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GOL;GDP;MES;3H4;ACP;
Tubulin-Z1492796719-complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;X0M;ACP;
Tubulin-[1,2]oxazoloisoindole-2e complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;LO9;ACP;
Tubulin-Dictyostatin complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GOL;GDP;7LZ;MES;ACP;
tubulin - cryptophycin-uD[Dab] complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;A1IHR;ACP;
Tubulin-[1,2]oxazoloisoindole-1 complex Heteromer
P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;LNU;IMD;ACP;
Phomopsin A in complex with tubulin Heteromer
P02554; Q2XVP4;
50-186
100.0GTP;MG;CA;CL;GDP;MES;HOS;ACP;
vinorelbine in complex with tubulin Heteromer
P02554; Q2XVP4;
50-186
100.0GTP;MG;CA;CL;GDP;MES;GDF;
The structure of SB-2-204-tubulin complex Heteromer
P63043; Q2XVP4; Q6B856;
50-186
100.0GTP;CA;CL;MG;GDP;MES;KB4;ACP;
Tubulin-Colchicine-Ustiloxin: Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-185
98.47GTP;MG;SO4;GDP;LOC;
T2R-TTL-1-K08 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-186
100.0GTP;MG;CA;GDP;MES;A1H01;IMD;ACP;
Tubulin-Vinblastine: Stathmin-like complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-185
98.47GTP;MG;SO4;GDP;VLB;
Tubulin-T138067: RB3 stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-185
100.0GTP;MG;T13;GDP;
Tubulin: RB3 Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-185
100.0GTP;MG;GDP;
Crystal structure of tubulin bound to compound 2 Heteromer
P63043; P81947; Q6B856;
49-185
99.17MG;GTP;CA;GDP;4EE;MES;IMD;
Tubulin-colchicine-soblidotin: Stathmin-like domain complex Heteromer
P63043; Q3ZCJ7; Q6B856;
49-185
100.0GTP;MG;GDP;LOC;TZT;
Tubulin-ABT751: RB3 stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-185
100.0GTP;MG;GDP;E70;
Tubulin-colchicine-phomopsin A: Stathmin-like domain complex Heteromer
P63043; Q3ZCJ7; Q6B856;
49-185
100.0MG;CN2;HOS;GTP;GDP;
Tubulin-baccatin III complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;R3Q;ACP;
Tubulin-taxane-2a complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;R42;ACP;
Crystal structure of tubulin-stathmin-TTL-ADP complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;CL;GDP;MES;ADP;GOL;
Crystal structure of T2R-TTL-taccalonolide AJ complex Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;TAJ;ACP;
Crystal structure of T2R-TTL-Y28 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;8WU;ACP;
Tubulin-Maytansine complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;3GT;ACP;
Crystal structure of T2R-TTL-Tivantinib complex Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;TIV;ACP;
Crystal structure of T2R-TTL-CH1 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;890;
Tubulin-todalam-4-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;47F;ACP;
Crystal structure of T2R-TTL -mebendazole complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;CL;GOL;GDP;MES;V95;IMD;ACP;
Tubulin-4AZA2996 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;RME;MES;ACP;
Complex of novel maytansinoid M24 bound to T2R-TTL (two tubulin alpha/beta heterodimers, RB3 stathm… Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;CL;EDO;GDP;MES;XQ4;ACP;
An apo tubulin-RB-TTL complex structure used for side-by-side comparison Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;CL;GDP;MES;ACP;
Tubulin - maytansinoid - 4 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;IMD;GDP;MES;Q0F;ACP;
Tubulin-maytansinoid-4b-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;GOL;IMD;5IJ;ACP;
Crystal structure of T2R-TTL-CF1 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;89C;
Tubulin-Eribulin complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;IMD;GOL;GDP;6K9;03S;MES;ACP;
Tubulin-GDP.AlF complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;CL;GOL;GDP;MES;AF3;IMD;ACP;
Tubulin-maytansinoid-5b-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;GOL;IMD;5KI;ACP;
The crystal structure of tubulin complexed with a benzylidene derivative of 9(10H)-anthracenone Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;89U;ACP;
Crystal structure of apo T2R-TTL Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;ACP;
Tubulin-Colchicine complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG; 13×GOL;CA;GDP;LOC;MES;PEG;IMD;ACP;
Tubulin-todalam-10-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;4FK;ACP;
Tubulin-TH588 complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;EDO;GDP;MES;2GE;ACP;
Tubulin-maytansinoid-5a-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;GOL;IMD;5JS;ACP;
Tubulin-taxane-2b complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;R3T;
Tubulin-RB3-TTL in complex with compound SI10 Heteromer
A0A287AGU7; A0A8V0Z8P0; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;A1D69;ACP;
Crystal structure of T2R-TTL-1129A2 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;MES;JEL;GDP;ACP;
Triazolopyrimidines stabilize microtubules by binding to the vinca inhibitor site of tubulin Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;GDP;8Z8;ACP;
Crystal structure of tubulin in complex with Ansamitocin P3 Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;BKF;ACP;
Tubulin-Jerantinine B acetate complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;EX5;EDO;ACP;
Crystal structure of T2R-TTL-Nocodazole complex Heteromer
A0A0R4I993; P32882; P63043;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;NZO;ACP;
Crystal structure of tubulin in complex with C(13)/C(13')-Bis-Desmethyl-Disorazole Z Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;GOL;CA;DMS;GDP;MES;M5U;ACP;
YDX in complex with tubulin Heteromer
P02554; Q2XVP4;
50-185
100.0GTP;MG;CA;GDP;MES;G70;ACP;
Structures of a beta-lactam bridged analogue in complex with tubulin Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG; 12×GOL;CA;GDP;MES;6ZR;IMD;
Quinolin-6-yloxyacetamides are microtubule destabilizing agents that bind to the colchicine site of… Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;GDP;MG;9N5;ACP;
Tubulin-maytansinoid-4a-complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;IMD;5IX;ACP;
Crystal Structure of Tubulin-Stathmin-TTL-Tubulysin M Complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;55Q;ACP;
Crystal structure of tubulin-stathmin-TTL-Compound TCA complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG; 11×GOL;CA;GDP;MES;97O;IMD;ACP;
Crystal structure of tubulin-stathmin-TTL-Compound 11 complex Heteromer
D0VWY9; D0VWZ0; P63043;
50-185
98.35GTP;MG;CA;GDP;6YK;ADP;
Structure of crolibulin in complex with tubulin Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;BG0;ACP;
Crystal structure of T2R-TTL-Lexibulin complex Heteromer
F2Z5B2; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;LXL;ACP;
Crystal structure of tubulin in complex with inhibitor D64 Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;GDP;MES;D3L;CA;ACP;
Crystal structure of T2R-TTL-28 complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;94U;NA;CL;ACP;
Crystal structure of tubulin-stathmin-TTL-Compound Z1 complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG; 12×GOL;CA;GDP;MES;84F;IMD;ACP;
Crystal structure of T2R-TTL-Plinabulin complex Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;MG;CA;GDP;MES;PN6;ACP;
crystal structure of T2R-TTL-(+)-6-Cl-JP18 complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;G9X;GDP;MES;GOL;IMD;
Crystal structure of tubulin in complex with D-DM1-SMe Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;HZ0;ACP;
Crystal structure of T2R-TTL-Erianin complex Heteromer
A0A287AGU7; A0A8V0Z8P0; P63043; P81947;
50-185
100.0GTP;MG;CA;GOL;MES;W4F;GDP;ACP;
Crystal structure of T2R-TTL-Demecolcine complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;LON;
Crystal structure of T2R-TTL-14b complex Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;7LG;ACP;
Crystal structure of tubulin bound to MI-181 Heteromer
P63043; P81947; Q6B856;
50-185
99.17GTP;MG;CA;GOL;GDP;4ED;MES;IMD;
CRYSTAL STRUCTURE OF T2R-TTL-8WR COMPLEX Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;MG;CA;GDP;MES;8WR;ACP;
Crystal structure of tubulin in complex with Tubulysin analogue TGL Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;J6R;ACP;
Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 8b Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;E9Y;ACP;
Crystal structure of T2R-TTL-PAC complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;AEU;ACP;
Crystal structure of T2R-TTL-Compound9 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;AF6;ACP;
Z-SolQ2Br bound to tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100GTP;MG;CA;GDP;V1O;ACP;
Crystal structure of T2R-TTL-Millepachine complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;8X0;ACP;
Tubulin-RB3_SLD-TTL in complex with compound 5m Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;Y5M;ACP;
Crystal structure of T2R-TTL-Compound11 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;AEX;ACP;
Crystal structure of T2R-TTL-PO10 complex Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;CA;MG;GDP;MES;87U;ACP;
Crystal structure of T2R-TTL-3a complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;MXV;ACP;
Crystal structure of DJ-101 in complex with tubulin protein Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;7Q7;ACP;
The structure of CH-II-77-tubulin complex Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;9WR;ACP;
Tubulin-RB3_SLD-TTL in complex with compound 5k Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;YJ7;GDP;MES;ACP;
Crystal structure of T2R-TTL-MPC6827 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;88U;
The structure of MT189-tubulin complex Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;9LX;ACP;
Crystal structure of T2R-TTL-PO5 complex Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;MG;CA;GDP;MES;PN6;ACP;
The crystal structure of tubulin in complex with 4'-demethylepipodophyllotoxin Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;89O;ACP;
EPD in complex with tubulin Heteromer
P02554; Q2XVP4;
50-185
100.0GTP;MG;CA;CL;GDP;MES;EPD;ACP;
Tubulin-RB3_SLD-TTL in complex with compound 13f Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;G9K;ACP;
Tubulin-RB3_SLD-TTL in complex with compound 5l Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;Y5L;ACP;
Crystal structure of T2R-TTL-Colchicine complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;LOC;
Tubulin-RB3_SLD-TTL in complex with compound 5j Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;GDP;MES;Y5J;ACP;
Crystal structure of Tubulin-Stathmin-TTL-Thiocolchicine Complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CL;GDP;MES;71P;CA;
Crystal structure of T2R-TTL-DPP21 complex Heteromer
A0A287AGU7; A0A8V0Z8P0; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;A1D8I;ACP;
Long wavelength native-SAD phasing of Tubulin-Stathmin-TTL complex Heteromer
P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;CL;GDP;MES;ACP;
Crystal structure of T2R-TTL bound with PO-7 Heteromer
A0A0R4I993; A0A0R4I995; P63043;
50-185
100.0GTP;MG;CA;GDP;MES;PO7;ACP;
Colchicine bound to tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100GTP;MG;CA;GDP;LOC;ACP;
Crystal structure of T2R-TTL-Y50 complex Heteromer
P02554; P63043; Q2XVP4;
50-185
100.0GTP;MG;CA;GOL;GDP;MES;Y50;ACP;
Crystal Structure of T2R-TTL complex with 7a3 Heteromer
P63043; Q2XVP4; Q6B856;
50-185
100.0GTP;MG;CA;GDP;MES;96C;ACP;
Ansamitocin P3 bound to tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-185
100.0GTP;MG;CA;GDP;BKF;ACP;
Tubulin-RB3-TTL in complex with compound SI10 Heteromer
A0A287AGU7; A0A8V0Z8P0; P63043; Q2XVP4;
50-185
100.0GTP;CA;MG;A1D7A;GDP;MES;ACP;
Tubulin-TN16 : RB3 stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-184
100.0GTP;MG;GDP;N16;
TUBULIN-NSC 613863: RB3 Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-184
100.0GTP;MG;GDP;G2N;
TUBULIN-NSC 613862: RB3 Stathmin-like domain complex Heteromer
D0VWY9; D0VWZ0; P63043;
49-184
100.0GTP;MG;GDP;K2N;
Tubulin-podophyllotoxin: stathmin-like domain complex Heteromer
P63043; Q2HJ86; Q6B856;
50-185
100.0MG;GTP;GDP;POD;
Tubulin-Rhizoxin complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG;CA;GDP;MES;36L;ACP;
Tubulin-vinblastine complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG;CA;VLB;GDP;MES;
Tubulin-maytansinoid-4c-complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG;CA;GDP;MES;GOL;IMD;5JH;ACP;
Tubulin-RB3_SLD in complex with compound 40a Heteromer
P02554; P63043; Q2XVP4;
50-184
98.4GTP;SO4;GDP;TU3;MG;DMS;
Tubulin-RB3_SLD-TTL in complex with SB226 Heteromer
P02554; P63043; Q2XVP4;
50-184
100.0GTP;CA;MG;DMS;GDP;MES;JVI;GOL;ACP;
Tubulin-6j complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG;CA;GDP;EZW;MES;ACP;
Tubulin-Pelophen B complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG;GOL;CL;CA;GDP;MES;K9I;DMS;ACP;
tubulin-AB8939 complex Heteromer
A0A836D7T3; D0VWY9; P63043;
51-185
98.28GTP;MG;GDP;UIY;SO4;
Crystal structure of tubulin-stathmin-TTL-Compound Z2 complex Heteromer
P63043; P81947; Q6B856;
50-184
100.0GTP;MG; 12×GOL;CA;GDP;MES;93X;IMD;ACP;
Tubulin-RB3_SLD in complex with compound 60c Heteromer
P02554; P63043; Q2XVP4;
50-184
98.4GTP;SO4;GDP;TU2;MG;
a new complex structure of tubulin with an alpha-beta unsaturated lactone Heteromer
P02554; P63043; Q2XVP4;
50-184
100.0GTP;MG;CA;GDP;MES;X3H;ACP;
Structural basis of tubulin and heterocyclic podophyllotoxins complex for anticancer agents with du… Heteromer
A0A287AGU7; A0A8C9FGJ1; P63043; Q2XVP4;
50-184
100.0GTP;MG;CA;GOL;PEG;GDP;MES;A1D55;EDO;ACP;
Crystal structure analysis of tubulin and heterocyclic podophyllotoxins complex for anticancer agen… Heteromer
A0A287AGU7; A0A8C9FGJ1; P63043; Q2XVP4;
50-184
100.0GTP;MG;EDO;PEG;GDP;MES;WIW;CA;ACP;
Tubulin-RB3_SLD-TTL in complex with compound 5t Heteromer
P02554; P63043; Q2XVP4;
50-184
100.0GTP;CA;MG;CL;GDP;MES;YJ4;ACP;
Vinblastine bound to tubulin (T2R-TTL) complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-184
100GTP;MG;CA;VLB;GDP;
TUBULIN-Compound 12 complex Heteromer
P63043; P81947; Q6B856;
51-184
100.0GTP;MG;CA;GDP;CVT;MES;ACP;
Tubulin-RB3_SLD in complex with compound 12k Heteromer
P02554; P63043; Q2XVP4;
51-184
98.37GTP;SO4;GDP;JV9;GOL;MG;
Tubulin-RB3_SLD in complex with compound 12e Heteromer
P02554; P63043; Q2XVP4;
51-184
98.39GTP;SO4;GDP;JUL;MG;
DZ-2384 tubulin complex Heteromer
P63043; P81947; Q6B856;
52-185
100.0GTP;MG;CA;GDP;MES;71E;ACP;
Crystal structure of T2R-TTL-PM534 complex Heteromer
A0A8V0Z8P0; P63043; P81947; Q6B856;
50-183
100.0GTP;GOL;CA;MG;CL;GDP;MES;KG0;DMS;ACP;
Tubulin-RB3_SLD in complex with colchicine Heteromer
P02554; P63043; Q2XVP4;
51-184
98.33GTP;MG;SO4;GDP;LOC;
Tubulin-RB3_SLD in complex with compound 12j Heteromer
P02554; P63043; Q2XVP4;
51-184
98.37GTP;SO4;GDP;JVR;MG;
Tubulin-RB3-TTL in complex with compound SI9 Heteromer
A0A287AGU7; A0A8V0Z8P0; P63043; Q2XVP4;
50-182
100.0GTP;CA;MG;GDP;MES;A1D68;ACP;
Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications Heteromer
D0VWY9; D0VWZ0; P63043;
53-185
98.37GTP;MG;GDP;LOC;3WD;
Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications Heteromer
D0VWY9; D0VWZ0; P63043;
53-185
98.37GTP;MG;GDP;LOC;3WV;
Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications Heteromer
D0VWY9; D0VWZ0; P63043;
53-185
98.37GTP;MG;GDP;LOC;3WY;
Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications Heteromer
D0VWY9; D0VWZ0; P63043;
53-185
98.37GTP;MG;GDP;LOC;3WZ;
Tubulin-GDP.BeF complex Heteromer
P63043; P81947; Q6B856;
52-183
100.0GTP;MG;CA;GDP;MES;BEF;ACP;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7cbz.1.Emonomer0.6350-187
100.00
9f07.1.Cmonomer0.5349-185
89.53